Towards SARS-CoV-2 serotypes?

The magnitude of immune evasion of Omicron raises the question whether it should be considered as a distinct SARS-CoV-2 serotype. Here, we discuss lines of evidence in support or against the concept of SARS-CoV-2 serotypes, and the implications of this classification.

Detalles Bibliográficos
Autores principales: Simon-Loriere, Etienne, Schwartz, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855751/
https://www.ncbi.nlm.nih.gov/pubmed/35181769
http://dx.doi.org/10.1038/s41579-022-00708-x
Descripción
Sumario:The magnitude of immune evasion of Omicron raises the question whether it should be considered as a distinct SARS-CoV-2 serotype. Here, we discuss lines of evidence in support or against the concept of SARS-CoV-2 serotypes, and the implications of this classification.

Ejemplares similares